This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Cephalon, Inc., Mcmaster University. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Parameswaran Nair: Innovator in Eosinophilic Asthma Treatment
Introduction
Parameswaran Nair is a distinguished inventor based in Dundas, Canada. He has made significant contributions to the field of medical research, particularly in the treatment of severe glucocorticoid-dependent eosinophilic asthma. With a total of 2 patents to his name, Nair's work has the potential to impact many lives.
Latest Patents
Nair's latest patents include groundbreaking innovations such as "DNA APTAMERS FOR EOSINOPHIL PEROXIDASE DETECTION" and a treatment strategy for non-responders to 100MG subcutaneous mepolizumab. These patents disclose methods for treating severe glucocorticoid-dependent eosinophilic asthma in subjects whose condition has been inadequately controlled with subcutaneously administered mepolizumab. Additionally, they provide methods for predicting responsiveness to anti-IL-5 antibody treatment in affected individuals.
Career Highlights
Throughout his career, Nair has worked with notable organizations, including Cephalon, Inc. and McMaster University. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.
Collaborations
Some of Nair's coworkers include Manali Mukherjee and John D Brennan. Their collaborative efforts have contributed to the advancement of research in eosinophilic asthma treatment.
Conclusion
Parameswaran Nair's innovative work in the field of eosinophilic asthma treatment showcases his dedication to improving patient outcomes. His patents and collaborations reflect a commitment to advancing medical science and providing effective solutions for those in need.